An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone posted a short personal update about switching diabetes/weight drugs and asked whether their first injection (pen) counts as a success. In plain terms: they’d been on the oral drug Rybelsus (a pill) for about a year and lost some weight but hit a plateau. They recently switched to Mounjaro (an injectable medication) and are asking if the change is doing what it should. Mounjaro is the brand name for tirzepatide, a medicine you get as a shot. It works by acting like natural gut hormones that help control blood sugar and reduce appetite; that’s why people use it for type 2 diabetes and to help with weight loss. Rybelsus (semaglutide by mouth) is a different medicine that also mimics a gut hormone to lower appetite and slow stomach emptying. Both change the signals from your gut to your brain about hunger and fullness, but they’re different drugs and can work differently for different people. The post is a single-person anecdote, not a formal study. The person reports going from about 396 to 365 pounds over a year on Rybelsus, then hitting a weight-loss plateau (“flatlining”), and now being switched to Mounjaro. That tells us one thing: Rybelsus produced modest weight loss for them (about 31 pounds), but progress stalled. We don’t know how long they’ve been on Mounjaro yet or whether it will lead to more loss. Anecdotes are useful for personal perspective but can’t tell us how the drugs perform on average or long-term. Why this matters: many people considering these medicines want to know if switching drugs helps when one stops working. This post highlights a common situation — initial benefit then plateau — and the next step some clinicians take is to try a different medication class. If you or someone has struggled with weight despite lifestyle changes, medications like semaglutide or tirzepatide can be meaningful tools. But individual results vary, and what works for one person might not for another. Important caveats: this is one person’s report, not evidence of effectiveness for everyone. Both drugs have side effects (nausea, stomach upset, sometimes more serious risks) and are prescribed by doctors based on overall health and medications you already take. People with certain conditions or on certain medicines shouldn’t use them without medical advice. Also, insurance coverage and long-term safety and weight maintenance are ongoing questions in the medical community. Bottom line: the post shows a real-life example of switching therapies after a plateau, but it doesn’t prove that Mounjaro will be a success for this person or in general.
Source: r/Mounjaro